You have to be registered and logged in for purchasing articles.
Abstract |
Blood Products Management and Safety During COVID-19: a Public Health Challenge |
|
Background: Blood products are essential therapeutics that are pivotal in saving and improving millions of lives worldwide. A sufficient and safe blood supply is necessary for efficient healthcare services to provide effective patient care in various acute and chronic conditions. Blood donations are the main source of blood products in almost all nations of the world. The coronavirus 2019 (COVID-19) pandemic negatively impacted blood product management worldwide and has added stress to the already stressed healthcare system. Most of the earlier months of 2020 witnessed a decrease in blood donations as donors were highly apprehensive about their safety, and the isolation practices implemented to contain the virus spread discouraged donor participation. Because of the spread of the virus, blood collection centers and regulatory bodies have undertaken numerous strategic steps to prevent any viral transmission at the blood collection centers while aiming to increase donor participation. Maintaining extra sterilization in all the processes involved in blood product management and the modified criteria for participating donors changed the entire paradigm of blood product management. This review discusses various challenges and modifications adopted by different roles of participants involved in blood product availability to maintain an adequate and safe blood supply during the emerging COVID-19 pandemic.
|
|
